ISIS 5132 in Treating Patients With Metastatic or Recurrent Ovarian Cancer
Status:
Completed
Trial end date:
2008-09-22
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of ISIS 5132 in treating patients who have
metastatic or recurrent ovarian cancer that has not responded to previous chemotherapy.